Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes
globenewswire.com
TARMAT.BOTARMAT.BOBSE
Loading
No data available
Alerts
Want to monitor TARMAT.BO?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor TARMAT.BOFinancialsFull statements →
Gross Margin
6.8%
Operating Margin
1.4%
Net Margin
1.8%
Revenue Growth
+13.4%
FCF Margin
-36.8%
Debt/Equity
0.06x
News
Nokia and Turkcell transform fixed network operations in Türkiye with proactive AI intelligence
globenewswire.com
Video - CEO Clips: Cosa Resources Advances Uranium Exploration in the Athabasca Basin
newsfilecorp.com
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
businesswire.com
Japan rejects U.S. intel assessment that Takaichi's Taiwan remarks represent 'significant shift'
cnbc.com
Eight states sue to block Nexstar's plan to acquire rival Tegna
reuters.com
Accenture plc (ACN) Presents at Reinventing AI Strategy for 2026 Transcript
seekingalpha.com
CoreWeave: Deeply Undervalued Against Peers
seekingalpha.com
Asia tech stocks sink as oil spike and Qatar attacks threaten chip supply chain
cnbc.com
2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow
fool.com
S&P Global Inc. (SPGI) Presents at Reinventing AI Strategy for 2026 Transcript
seekingalpha.com
Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
accessnewswire.com
HDFC Bank hits 52-week low: did Chairman's exit signal trouble?
invezz.com
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock
seekingalpha.com
Forget the War Headlines: This Is the Real Reason Tech Stocks Are Struggling
fool.com
Oil Prices Surge After Middle East Strikes: Is Crude Heading Toward $150 Next?
fxempire.com
Nvidia Is the Ultimate Growth Stock to Buy Now -- Here's Why
fool.com
Citigroup and 5 More Bank Stocks Set to Thrive in a Choppy Market
barrons.com
AI Disruption Fears Create An Opportunity In Willis Towers Watson
seekingalpha.com
AstraZeneca says it will build cell therapy base, innovation centre in Shanghai
reuters.com
About
No company information available